Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

CARDIOME PHARMA CORP (COM)
Mes dernières consult.
Most popular
Report
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a pharmaceutical company, which engages in the provision of development and commercialization of medical products.

It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.

It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

Sales per Businesses
20152016Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies26.75100%33.46100% +25.08%
Sales per Regions
20152016Delta
CAD (in Million)%CAD (in Million)%
Europe13.5350.6%14.4843.3% +7.08%
Rest of World13.2349.4%18.9856.7% +43.5%
Managers
NameAgeSinceTitle
William L. Hunter, MD532007President, Chief Executive Officer & Director
William James O'Shea672014Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Justin A. Renz MBA, CPA452017Chief Financial Officer
Richard M. Glickman, PhD592006Lead Independent Director
Mark H. N. Corrigan, MD602015Director
Arthur H. Willms772015Independent Director
Robert James Meyer, MD-2015Director
Jennifer Archibald-2006Chief Business Operations Officer
Steen Juul-Möller MD, PhD-2013Medical Director-Europe
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 34,628,842 32,947,791 95.1% 0 0.0% 95.1%
Shareholders
NameEquities%
Westfield Capital Management Co. LP 4,931,969 15.5%
Putnam Investment Management LLC 3,924,346 12.3%
Stonepine Capital Management LLC 3,158,816 9.91%
Clough Capital Partners LP 2,878,985 9.03%
Tamarack Advisers LP 1,825,000 5.73%
Rock Springs Capital Management LP 1,200,000 3.76%
William L. Hunter, MD 814,304 2.55%
AlphaOne Investment Services LLC 600,625 1.88%
Renaissance Technologies LLC 411,413 1.29%
JPMorgan Securities LLC (Investment Management) 158,697 0.50%
Company contact information
Cardiome Pharma Corp.
1441 Creekside Drive
6th floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP-52.02%52
BIOGEN18.26%65 516
CSL LIMITED43.07%49 706
ALEXION PHARMACEUTICALS-11.69%24 039
GRIFOLS SA33.08%18 690
BIOMARIN PHARMACEUTICAL0.18%14 575
CHONGQING ZHIFEI BIOLOGICAL PRDCT CO LTD--.--%6 794
3SBIO INC98.68%5 152
ABCAM PLC30.64%2 732
BOYA BIO-PHARMACEUTICAL GROUP CO LTD--.--%1 827
HUGEL INC--.--%1 754
BIOTEST AG32.11%936
ANIKA THERAPEUTICS INC11.87%799
PROMETIC LIFE SCIENCES INC.-37.72%793
PHARMA MAR SA-11.81%630
WILSON THERAPEUTICS AB103.74%357
SYROS PHARMACEUTICALS INC9.38%356
CHEMOCENTRYX INC-5.14%341
KADMON HOLDINGS INC-34.21%277
STRONGBRIDGE BIOPHARMA PLC164.58%261
CO DON AG272.94%234
Connections : Cardiome Pharma Corp
Zalicus Pharmaceuticals Ltd.
Kyowa Kirin International Plc
Advanced Applied Physics Solutions, Inc.
Nabriva Therapeutics AG
Trevi Therapeutics, Inc.
The Vancouver Symphony Foundation
Premier's Technology Council
Virginia Center For Translational & Regulatory Sciences
Quartet Medicine, Inc.
Brighton Biotech, Inc.
Michael Smith Foundation for Health Research
Richardson Capital Ltd.
Synereca Pharmaceuticals, Inc.
enGene, Inc.
Pamlico BioPharma, Inc.
MedGenesis Therapeutix, Inc.
Vancouver Symphony Orchestra
Vida Pharmaceuticals Pvt Ltd.
British Columbia Lottery Corp.
Kearny Venture Partners
The 2010 Games Operating Trust
Lumira Capital Investment Management, Inc.
Pacific Autism Family Centre Foundation
Blackthorn Therapeutics, Inc.
Correvio International SARL
© 2017 People , Fundamentals and Ownership